Factor analysis of subjective descriptors of chronic pruritus and association with quality of life: A cross-sectional survey - 06/03/20
Funding sources: Supported in part by the Veterans Affairs Rehabilitation Research and Development Merit Review (project number F4529I) under “Veteran Impact of Chronic Pruritus: the Skin Equivalent of Chronic Pain” and by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number UL1TR002378 and KL2TR002381 (to Dr Yeung). |
|
Disclosure: Dr Yosipovitch has received honoraria and research support from Menlo, Trevi, Sienna, Sanofi Regeneron, Galderma, Novartis, Eli Lilly, Pfizer, Kiniksa, Sun Pharma, Leo, Bellus, AbbVie, Bayer, and CeraVe. Dr Chen has received copyright royalties from Menlo. Dr Yeung has received honoraria from Syneos Health. Ms Rolader, Ms DeGrazia, and Dr Zhang have no conflicts of interest to declare. |
|
IRB approval status: Reviewed and approved by the Emory IRB. |
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?